US 11407748
Substituted pyrido[1,2-a]pyrimidines and pyrazino[1,2-a]pyrimidines for enhancing AMPA receptor function
granted A61KA61K31/517A61K31/519
Quick answer
US patent 11407748 (Substituted pyrido[1,2-a]pyrimidines and pyrazino[1,2-a]pyrimidines for enhancing AMPA receptor function) held by Takeda Pharmaceutical Company Limited expires Mon Aug 04 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Aug 09 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 04 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/517, A61K31/519, A61K31/5377, A61K31/538